These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol. Barbier GH; Shettigar UR; Appunn DO Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691 [TBL] [Abstract][Full Text] [Related]
4. Esmolol HCl. Marden SF; Chulay M Crit Care Nurse; 1989; 9(10):12-4. PubMed ID: 2574652 [No Abstract] [Full Text] [Related]
5. Esmolol in the treatment of supraventricular tachyarrhythmias. Das G; Ferris J Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451 [TBL] [Abstract][Full Text] [Related]
6. [Successful control of rapid heart rate with atrial flutter by intravenous administration of esmolol in a patient after total correction of the tetralogy of Fallot]. Masamune T; Suzuki S; Nonaka A; Imamura M; Abe F Masui; 2004 Aug; 53(8):918-20. PubMed ID: 15446684 [TBL] [Abstract][Full Text] [Related]
7. Esmolol in the treatment of multifocal atrial tachycardia. Hill GA; Owens SD Chest; 1992 Jun; 101(6):1726-8. PubMed ID: 1350974 [TBL] [Abstract][Full Text] [Related]
11. Esmolol: a unique drug with ED applications. Frakes MA J Emerg Nurs; 2001 Feb; 27(1):47-51. PubMed ID: 11174271 [No Abstract] [Full Text] [Related]
12. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients. Ko WJ; Chu SH J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. Das G; Tschida V; Gray R; Dhurandhar R; Lester R; McGrew F; Askenazi J; Kaplan K; Emanuele M; Turlapaty P J Clin Pharmacol; 1988 Aug; 28(8):746-50. PubMed ID: 2905710 [TBL] [Abstract][Full Text] [Related]
14. Treatment of caffeine toxicity with esmolol. Price KR; Fligner DJ Ann Emerg Med; 1990 Jan; 19(1):44-6. PubMed ID: 1688693 [TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic strategies for the chronic management of supraventricular tachycardias. Pritchett EL; Anderson JL Am J Cardiol; 1988 Aug; 62(6):1D-2D. PubMed ID: 2900603 [No Abstract] [Full Text] [Related]
16. Maternal esmolol administration resulting in fetal distress and cesarean section in a term pregnancy. Ducey JP; Knape KG Anesthesiology; 1992 Oct; 77(4):829-32. PubMed ID: 1358006 [No Abstract] [Full Text] [Related]
17. New pharmacologic agents for emergency management of supraventricular tachydysrhythmias. Paul SC Crit Care Nurs Q; 1993 Aug; 16(2):35-45. PubMed ID: 8102589 [No Abstract] [Full Text] [Related]
18. Comparative effects of esmolol and verapamil in a model of a supraventricular tachydysrhythmia. Tuman KJ; McCarthy RJ; Wong CA; Labarge AM; Spiess BD; Ivankovich AD Anesthesiology; 1990 Sep; 73(3):467-73. PubMed ID: 1975485 [TBL] [Abstract][Full Text] [Related]
19. Common supraventricular arrhythmias in Indian population and their management. Sharada K; Narasimhan C J Indian Med Assoc; 2003 Feb; 101(2):75-6, 78-80. PubMed ID: 12841487 [TBL] [Abstract][Full Text] [Related]
20. Short-acting beta-adrenergic blockade and the fetus. A case report. Gilson GJ; Knieriem KJ; Smith JF; Izquierdo L; Chatterjee MS; Curet LB J Reprod Med; 1992 Mar; 37(3):277-9. PubMed ID: 1348787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]